The Cannabis ETF (THCX)
ARCA ARCA Primary 
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pressures, but has significant upside potential with strategic buyers potentially paying mid- or high-teens per share. Casey's General Stores has outperformed its peers and the S&P 500 due to its strategic positioning in rural areas and strong operational execution.
Cannabis REITs with Strong Dividend Yields for Your Investment Portfolio
As the cannabis market experiences a pullback, interest is growing in cannabis-focused REITs, which offer a unique approach to investing in this evolving industry. REITs are known for providing steady dividends, making them attractive for income-seeking investors during market downturns. The US cannabis market is projected to reach $41 billion by 2025, highlighting its long-term potential. This industry growth and ongoing legalization efforts bring attention to cannabis REITs as indirect investments. Recently, legalization headlines have fueled volatility, making risk management and technical analysis essential for investors aiming to time their entries and exits wisely.
Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?
In the latest cannabis market analysis from Beacon Securities , three major multi-state operators (MSOs) Village Farms, Green Thumb Industries, and Jushi Holdings—demonstrate distinct strategies for navigating the challenging landscape.
Top Marijuana Stocks to Watch as the Cannabis Market Faces Decline
The US cannabis market recently experienced a notable pullback, creating fresh opportunities to watch top marijuana stocks. With a potential shift in federal reform under a Republican-led government, investors are increasingly optimistic about the industry's regulatory future. The US cannabis industry, currently valued at over $30 billion, is projected to grow by nearly 15% annually. This growth underscores its resilience and potential for expansion as more states consider legalization. Recent headlines on state-level legalization and discussions on federal reform continue to highlight the sector's momentum. Although challenges remain, the long-term outlook is promising.
Aurora Cannabis: Buy The Election Overreaction
Aurora Cannabis dropped over 10%, along with the broader cannabis market, due to concerns over U.S. election results. Despite this, Aurora has no U.S. cannabis operations and is unaffected. Aurora reported robust revenue growth, with a 29% YoY increase, driven by a 93% rise in international medical cannabis sales. The company re-affirmed positive free cash flow expectations for Q3 and demonstrated strong spending discipline, maintaining positive adjusted EBITDA for the 8th consecutive quarter.
Best Ancillary Cannabis Stocks Positioned for Growth Amid Market Pullback
As the US cannabis industry continues to grow, investor interest remains high. The market, valued at over $13 billion in 2023, is projected to exceed $30 billion by 2025. Despite this positive outlook, recent setbacks have caused a decline in cannabis stocks. One significant blow was Florida's failure to pass Amendment 3, which would have expanded legalization in a crucial state market. This decision has added volatility to the sector. Even so, there is ongoing optimism fueled by pending federal legislation. Any progress on these bills could create fresh momentum for cannabis stocks, underscoring the sector's potential for long-term growth.
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Top Picks for Ancillary Cannabis Stocks During the Marijuana Market Downturn
As the cannabis market faces recent fluctuations, ancillary cannabis stocks present a unique opportunity for investors. Ancillary companies, which supply essential tools and services to growers and retailers, often show resilience during market downturns. The US cannabis industry continues its growth trajectory, valued at over $13 billion in 2023, with projections suggesting it will reach $40 billion by 2030. However, Amendment 3's failure in Florida has recently sparked a pullback. This setback has stalled expansion in one of the country's largest potential cannabis markets. Despite this, federal legalization talks persist, with recent headlines hinting at possible reform that could boost investor confidence.
Trulieve Cannabis: Huge Florida Disappointment
Trulieve Cannabis Corp. faced a setback as Florida failed to approve recreational cannabis, despite 57% voter support, missing the 60% requirement. The MSO spent $145 million on the campaign, due to Florida's $5-$6 billion cannabis market potential. The company reported Q3 '24 results showed only modest 3% sales growth, though positive adjusted EBITDA remains strong when excluding the potential tax hits.
Cannabis stocks tank as Florida votes against recreational marijuana
Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up to three ounces of marijuana, failed to obtain the required 60% of support from voters yesterday.
Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up
As the election approaches, Canadian cannabis stocks are capturing attention, especially with potential U.S. legalization developments on the horizon. The U.S. cannabis industry is booming, with projected growth reaching $41 billion by 2025. This massive market is appealing to Canadian companies seeking new revenue streams. Florida, in particular, is considering the legalization of recreational cannabis, which could unlock significant growth for Canadian cannabis companies with existing U.S. ties. If Florida joins the ranks of legal states, Canadian companies like Tilray, Canopy Growth, and Cronos Group could capitalize on this opportunity. These stocks are increasingly appealing to investors looking to benefit from potential changes in the U.S. market.
Top Marijuana Stocks For Cannabis Investors In 2024
This past week was the time to find top marijuana stocks to buy. Why you ask well it's becuase of the volatile decline that took place. Now just becuase this recent pullback led to more buys doesn't mean it did not have a negative impact. With all the uproar about the presidential election and the need for more cannabis support, you would speculate better trading would happen. Yet this was not the case but there is still hope for the near future.
